CS194746B2 - Process for preparing new 11-deoxy-omega-pentanorprostaglandines - Google Patents

Process for preparing new 11-deoxy-omega-pentanorprostaglandines

Info

Publication number: CS194746B2
Authority: CS; Czechoslovakia
Prior art keywords: pentanorprostaglandines; deoxy; omega; preparing new; preparing
Prior art date: 1974-12-11

Application number

CS771242A

Other languages

Czech (cs)

Inventor

Michael R Johnson

Thomas K Schaaf

James F Eggler

Jasjit S Bindra

Hans-Jurgen E Hess

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1974-12-11

Filing date

1975-12-11

Publication date

1979-12-31

1975-12-11 Application filed by Pfizer filed Critical Pfizer

1979-12-31 Publication of CS194746B2 publication Critical patent/CS194746B2/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C61/06—Saturated compounds having a carboxyl group bound to a five-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1896—Compounds having one or more Si-O-acyl linkages
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
- C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Epidemiology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Crystallography & Structural Chemistry (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Emergency Medicine (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Furan Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyrane Compounds (AREA)

CS771242A 1974-12-11 1975-12-11 Process for preparing new 11-deoxy-omega-pentanorprostaglandines CS194746B2 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US53167674A	1974-12-11	1974-12-11

Publications (1)

Publication Number	Publication Date
CS194746B2 true CS194746B2 (en)	1979-12-31

Family

ID=24118594

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
CS771242A CS194746B2 (en)	1974-12-11	1975-12-11	Process for preparing new 11-deoxy-omega-pentanorprostaglandines
CS758428A CS194733B2 (en)	1974-12-11	1975-12-11	Method of producing novel 11-deoxy-omega-pentanorprostaglandins
CS771241A CS194745B2 (en)	1974-12-11	1975-12-11	Method of producing enones

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
CS758428A CS194733B2 (en)	1974-12-11	1975-12-11	Method of producing novel 11-deoxy-omega-pentanorprostaglandins
CS771241A CS194745B2 (en)	1974-12-11	1975-12-11	Method of producing enones

Country Status (22)

Country	Link
JP (3)	JPS51125257A (en)
AT (1)	AT351185B (en)
BE (1)	BE836564A (en)
BG (1)	BG27227A3 (en)
CH (1)	CH610302A5 (en)
CS (3)	CS194746B2 (en)
DD (3)	DD125828A5 (en)
DE (1)	DE2555210A1 (en)
DK (1)	DK559975A (en)
ES (1)	ES443421A1 (en)
FI (1)	FI753475A (en)
FR (1)	FR2293923A1 (en)
GB (3)	GB1508169A (en)
GR (1)	GR60310B (en)
IE (1)	IE43815B1 (en)
IL (2)	IL48617A0 (en)
LU (1)	LU73997A1 (en)
NL (1)	NL166015C (en)
NO (1)	NO754195L (en)
NZ (1)	NZ179502A (en)
SE (1)	SE7513602L (en)
ZA (1)	ZA747723B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5486540A (en) *	1993-10-28	1996-01-23	Allergan, Inc.	Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents
KR20010074981A (en)	1998-09-14	2001-08-09	우에노 도시오	ω-SUBSTITUTED PHENYL-PROSTAGLANDIN E DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT
BRPI0619492A2 (en) *	2005-12-07	2011-10-04	Univ Ramot	jasmonate chemical derivatives, pharmaceutical compositions and methods of use
US9284274B2 (en)	2005-12-07	2016-03-15	Ramot At Tel-Aviv University Ltd.	Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
US9284252B2 (en)	2009-06-09	2016-03-15	Sepal Pharma Ltd.	Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders
CA2879507A1 (en)	2012-07-19	2014-01-23	Cayman Chemical Company, Inc.	Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated disease and conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NO143741C (en) *	1972-07-13	1981-04-08	Pfizer	ANALOGY PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE PROSTAGLAND CONNECTIONS OF THE E AND F SERIES

1974
- 1974-12-04 ZA ZA747723A patent/ZA747723B/en unknown
1975
- 1975-11-11 GR GR49337A patent/GR60310B/en unknown
- 1975-12-02 SE SE7513602A patent/SE7513602L/en unknown
- 1975-12-03 IE IE2635/75A patent/IE43815B1/en unknown
- 1975-12-08 IL IL48617A patent/IL48617A0/en unknown
- 1975-12-09 DE DE19752555210 patent/DE2555210A1/en active Pending
- 1975-12-10 FI FI753475A patent/FI753475A/fi not_active Application Discontinuation
- 1975-12-10 NO NO754195A patent/NO754195L/no unknown
- 1975-12-10 GB GB29060/77A patent/GB1508169A/en not_active Expired
- 1975-12-10 GB GB50700/75A patent/GB1508168A/en not_active Expired
- 1975-12-10 DK DK559975A patent/DK559975A/en not_active Application Discontinuation
- 1975-12-10 NZ NZ179502A patent/NZ179502A/en unknown
- 1975-12-10 GB GB29061/77A patent/GB1508170A/en not_active Expired
- 1975-12-11 NL NL7514446.A patent/NL166015C/en not_active IP Right Cessation
- 1975-12-11 ES ES443421A patent/ES443421A1/en not_active Expired
- 1975-12-11 CS CS771242A patent/CS194746B2/en unknown
- 1975-12-11 CH CH1610875A patent/CH610302A5/en not_active IP Right Cessation
- 1975-12-11 LU LU73997A patent/LU73997A1/xx unknown
- 1975-12-11 BE BE1007076A patent/BE836564A/en not_active IP Right Cessation
- 1975-12-11 CS CS758428A patent/CS194733B2/en unknown
- 1975-12-11 BG BG031757A patent/BG27227A3/en unknown
- 1975-12-11 DD DD190054A patent/DD125828A5/xx unknown
- 1975-12-11 DD DD7500197926A patent/DD129649A5/en unknown
- 1975-12-11 AT AT941675A patent/AT351185B/en not_active IP Right Cessation
- 1975-12-11 CS CS771241A patent/CS194745B2/en unknown
- 1975-12-11 FR FR7537944A patent/FR2293923A1/en active Granted
- 1975-12-11 JP JP50148319A patent/JPS51125257A/en active Pending
- 1975-12-11 DD DD7500197925A patent/DD129783A5/en unknown
1977
- 1977-03-11 JP JP2687577A patent/JPS52102258A/en active Pending
- 1977-03-11 JP JP2687477A patent/JPS52102270A/en active Pending
1979
- 1979-03-13 IL IL56863A patent/IL56863A0/en unknown

Also Published As

Publication number	Publication date
NL166015C (en)	1981-06-15
IL56863A0 (en)	1979-05-31
DD129783A5 (en)	1978-02-08
IL48617A0 (en)	1976-02-29
BG27227A3 (en)	1979-09-14
GB1508169A (en)	1978-04-19
LU73997A1 (en)	1976-11-11
GB1508168A (en)	1978-04-19
AU8736275A (en)	1977-10-13
CS194733B2 (en)	1979-12-31
DD129649A5 (en)	1978-02-01
IE43815B1 (en)	1981-06-03
NZ179502A (en)	1979-01-11
JPS52102270A (en)	1977-08-27
ES443421A1 (en)	1977-04-16
CS194745B2 (en)	1979-12-31
FI753475A (en)	1976-06-12
ATA941675A (en)	1978-12-15
ZA747723B (en)	1976-11-24
JPS51125257A (en)	1976-11-01
BE836564A (en)	1976-06-11
NL7514446A (en)	1976-06-15
GR60310B (en)	1978-05-08
SE7513602L (en)	1976-06-14
IE43815L (en)	1976-06-11
DE2555210A1 (en)	1976-06-16
JPS52102258A (en)	1977-08-27
AT351185B (en)	1979-07-10
NL166015B (en)	1981-01-15
FR2293923A1 (en)	1976-07-09
DD125828A5 (en)	1977-05-18
FR2293923B1 (en)	1979-02-23
DK559975A (en)	1976-06-12
NO754195L (en)	1976-06-14
CH610302A5 (en)	1979-04-12
GB1508170A (en)	1978-04-19

Publication	Publication Date	Title
CS191275B2 (en)	1979-06-29	Process for preparing new 6-thiatetracyclines
CS183829B2 (en)	1978-07-31	Process for preparing thienamycine
HU174074B (en)	1979-10-28	Process for preparing 4-polyalkoxy-phenyl-2-pyrrolidone
JPS51125466A (en)	1976-11-01	Process for preparing graftcopolymer
HU171059B (en)	1977-10-28	Process for preparing pyridazinyl-benzimidazoles
HU173534B (en)	1979-06-28	Process for preparing new pseudotrisaccharides
HU171231B (en)	1977-12-28	Process for preparing iodo-polyvinyl-pyrrolidone
CS187466B2 (en)	1979-01-31	Process for preparing 2-arylamino-2-imidazolines
YU130775A (en)	1982-06-30	Process for preparing new pyridobenzodiazepines
HU172609B (en)	1978-11-28	Process for preparing new thiophene-saccharines
CS189730B2 (en)	1979-04-30	Process for preparing o-cyanazodyes
CS191290B2 (en)	1979-06-29	Process for preparing aminoalkylphenyletheres
HU175380B (en)	1980-07-28	Process for preparing thiol-carbamates
CS193518B2 (en)	1979-10-31	Process for preparing moenomycine
CS188259B2 (en)	1979-02-28	Process for preparing 2-anilinooxazoles
IL44361A0 (en)	1974-06-30	Process for preparing 3-fluoro-cephalosporins
CS193517B2 (en)	1979-10-31	Process for preparing new 2-arylamino-2-imidazolines
GB1486844A (en)	1977-09-28	Process for preparing 7beta-acylamino-7alpha-alkoxy-cephalosporins
CS188984B2 (en)	1979-03-30	Process for preparing 3-fluorbenzodiazepines
HU173847B (en)	1979-09-28	Process for preparing 6-methyl-8beta- isocyanomethyl-ergoline
HU172658B (en)	1978-11-28	Process for preparing benzene-sulphonyl-carbamides
HU172273B (en)	1978-07-28	Process for preparing 2-deutero-3-fluoro-dl-alanine
CS193512B2 (en)	1979-10-31	Process for preparing new 3-piperazinoisoquinolines
CS194746B2 (en)	1979-12-31	Process for preparing new 11-deoxy-omega-pentanorprostaglandines
CS188253B2 (en)	1979-02-28	Process for preparing 2-methyl-3-hydroxy-4-ethylaminomethyl-5-methylmercaptomethyl-pyridine